Key Trends Influencing the Growth of the Implantable Pulse Generator Market in 2025: Advancements In Neuromodulation Technology Enhanced Implantable Pulse Generators Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Implantable Pulse Generator Market Through 2025?
The market for implantable pulse generators has experienced a swift expansion in recent times. The size of the market is projected to escalate from $133.75 billion in 2024 to $148.38 billion in 2025, registering a compound annual growth rate (CAGR) of 10.9%. Factors such as the prevalence of home healthcare centers, the increased acceptance of neuromodulation for managing diseases, a higher rate of patient diagnosis, the growing utilization of medical devices, and heightened patient awareness have contributed to the market surge during the historical period.

What's the Projected Size of the Global Implantable Pulse Generator Market by 2029?
The market size for implantable pulse generators is projected to experience rapid expansion in the coming years, bolstering its value to $222.76 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this projected growth during the forecast period include escalating healthcare spending, patients' inclination towards less invasive treatments, advantageous reimbursement strategies, widening of application areas, and the increased use of implants in therapy. Throughout the forecast period, significant trends such as device miniaturization, improved battery longevity, wireless connectivity advancements, smart implantable devices, and the incorporation of artificial intelligence and machine learning, are expected to be seen.

View the full report here:
https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report

Top Growth Drivers in the Implantable Pulse Generator Industry: What's Accelerating the Market?
The implantable pulse generator market is forecasted to experience growth due to an increase in neurological disorders. These disorders, which affect the brain, spinal cord, and nervous system, influence functions like movement, sensation, and cognition. The surge in neurological disorder cases may be linked to factors such as aging populations, changes in lifestyle, environmental factors, and advancements in diagnostic techniques. Implantable pulse generators assist with these disorders by emitting specific electrical impulses to manage abnormal neural activity and relieve symptoms. For example, the Parkinson Foundation, a nonprofit organization based in the U.S., reported in December 2022 that by 2020, Parkinson's disease (PD) affected 930,000 individuals in the U.S., and the figure is anticipated to rise to 1.2 million by 2030. Consequently, the increasing prevalence of neurological disorders is propelling the growth of the implantable pulse generator market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp

What Trends Will Shape the Implantable Pulse Generator Market Through 2029 and Beyond?
Major players in the implantable pulse generator market are concentrating their efforts on the development of advanced neuromodulation appliances to augment treatment effectiveness, upgrade patient results, and broaden the use of these devices for an array of neurological conditions. Neuromodulation devices are specifically engineered medical apparatus for modifying nerve activities by enacting electrical or pharmaceutical agents directly towards certain regions of the nervous system. For instance, CVRx Inc, a US-based medical technology corporation, introduced its new product, Barostim NEO2 IPG, an implantable pulse generator for patients undergoing therapeutic procedures, in November 2022. By utilizing neuromodulation, the Barostim system ameliorates heart failure symptoms through the transmission of electrical pulses to the baroreceptors in the wall of the carotid artery. This activation prompts the body's baroreflex, causing a self-governing response in the heart. The aim of this treatment is restoring equilibrium to the autonomic nervous system and mitigating heart failure symptoms.

What Are the Main Segments in the Implantable Pulse Generator Market?
The implantable pulse generator market covered in this report is segmented -

1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices
2) By Charging Type: Rechargeable, Non Rechargeable
3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics

Subsegments:
1) By Implantable Cardiac Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers
2) By Implantable Defibrillators: Implantable Cardioverter Defibrillators (ICD), Subcutaneous Implantable Defibrillators (S-ICD)
3) By Cochlear Implants: Single-Channel Cochlear Implants, Multi-Channel Cochlear Implants
4) By Implantable Nerve Stimulators (Fes): Functional Electrical Stimulation (FES) Devices For Motor Function Restoration, Spinal Cord Stimulation Devices
5) By Implantable Infusion Pumps: Insulin Pumps, Pain Management Pumps, Intrathecal Drug Delivery Pumps
6) By Implantable Active Monitoring Devices: Continuous Glucose Monitoring Systems, Cardiac Monitoring Devices, Neurological Monitoring Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18639&type=smp

Which Top Companies are Driving Growth in the Implantable Pulse Generator Market?
Major companies operating in the implantable pulse generator market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Integer Holdings Corporation, Livanova plc, Inspire Medical Systems Inc., Nevro Corp, Impulse Dynamics Ltd., Valtronic Inc., NeuroPace Inc., SPR Therapeutics Inc., Stimwave LLC, SetPoint Medical, ReShape Lifesciences Inc., Synapse Biomedical Inc., Nuvectra Medical Inc., NeuroSigma Inc., Nalu Medical Inc., MainStay Medical International PLC, Dextronix Inc., BioControl Medical Inc.

Which Regions Will Dominate the Implantable Pulse Generator Market Through 2029?
North America was the largest region in the implantable pulse generator market in 2023. The regions covered in the implantable pulse generator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18639

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.